Fifth disease - Ọrịa Nke Ise
☆ Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ.
16 dị ọnwa nwere Ọrịa Nke Ise (Fifth disease) - Ntì abụọ ahụ na-acha uhie uhie, dị ka a ga-asị na a na-ama ya ụra, rashes maculopapular na-apụtakwa n'ahụ.
Erythema na ntì abụọ.
References
Fifth disease , nke a makwaara dị ka erythema infections, bụ ọrịa nje nke mmadụ parvovirus B19 kpatara. Ọ na-adịkarị na ụmụaka, na-emetụta ndị nọ n'agbata afọ 4 ruo 14. Mgbaàmà na-amalitekarị site na ahụ ọkụ dị nro, isi ọwụwa, akpịrị akpịrị, na mmetụta ndị yiri flu. Ụmụaka nwere ike ịmalite ihe ọkụ ọkụ na-acha uhie uhie dị iche na ihu nke yiri slapped cheeks , yana ihe ọkụ ọkụ na-eme n'ahụ, ogwe aka, na ụkwụ. Na ndị okenye, nkwonkwo mgbu bụ mkpesa nkịtị, nke nwere ike ịpụta izu ole na ole mgbe ọrịa mbụ gasịrị. N'ụzọ doro anya, ihe dị ka pasent 20 ruo 30 nke ndị okenye bu ọrịa parvovirus B19 nwere ike ọ gaghị egosipụta ihe mgbaàmà ọ bụla.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Ihe ize ndụ nke isi n'aka nne na-ebufe parvovirus B19 dị ihe dịka 33%, yana ihe dịka 3% nke ụmụ nwanyị bu ọrịa na-enwe nsogbu n'ime ụmụ ọhụrụ ha. Mgbe nne na-ebute ọrịa tupu izu 20 nke ime ime, ohere nke nsogbu dị ka nsogbu ọbara na mmụba mmiri n'ime ahụ nwa na-abawanye. Iji malite ịchịkwa ọrịa a, anyị kwesịrị ịlele ma ọ bụrụ na onye ọrịa ahụ ekpughere ya na parvovirus site na ịnwale ụfọdụ ọgwụ mgbochi (IgM) . Ọ bụrụ na ule ahụ egosighi ekpughere n'oge gara aga mana ọ na-egosi ọrịa na-adịbeghị anya, onye ọrịa chọrọ nlekọta anya n'oge ime ime, gụnyere nyocha nke ultrasound mgbe niile iji lelee ụfọdụ nsogbu ahụike nwa.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
ọrịa nke ise (fifth disease) na-amalite site na ahụ ọkụ na-adịghị ala ala, isi ọwụwa, ọkụ ọkụ, na ihe mgbaàmà ndị yiri oyi, dị ka imi na-agba agba ma ọ bụ nchichi. Mgbaàmà ndị a na-agafe, mgbe ụbọchị ole na ole gachara, ọkụ ọkụ na-apụta. Ihe ọkụ ọkụ na-acha uhie uhie na-apụtakarị na ihu, ọkachasị ntì. (ya mere aha ahụ bụ "ọrịa ntì mara mma"). Na mgbakwunye na ntì na-acha uhie uhie, ụmụaka na-enwekarị ihe ọkụ na-acha uhie uhie, nke na-adịghị mma n'ahụ ndị ọzọ, na ogwe aka elu, ọkpụkpụ na ụkwụ bụ ebe a na-ahụkarị.
Ọrịa a na-adịkarị obere, ma n'ime ụmụ nwanyị dị ime, ọrịa na-efe efe n'ime ọnwa mbụ nke mbụ ejikọtawo na hydrops fetalis, na-ebute ime ọpụpụ na mberede.
○ Ọgwụgwọ
Ọ dịghị ọgwụgwọ a kapịrị ọnụ achọrọ ka ọ na-akawanye mma ka oge na-aga.